Groupe la Francaise’s Verona Pharma VRNA Stock Holding History

Groupe la Francaise’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-127,309	Closed	-$13.6M	–	776
2025 Q3	$13.6M	Buy	+127,309	New	+$13.3M	0.18%	84

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Groupe la Francaise's VRNA Position: Q4 2025 in Review

Groupe la Francaise sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 127,309 shares — an estimated $13.6M sold.

Groupe la Francaise first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $13.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Groupe la Francaise reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 127,309 Verona Pharma shares in Q4 2025, an estimated $13.6M.
Groupe la Francaise first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's Verona Pharma position peaked at $13.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.